blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2906682

EP2906682 - BACTERIAL LIVE VECTOR VACCINES EXPRESSING CHROMOSOMALLY-INTEGRATED FOREIGN ANTIGENS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  06.07.2018
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  12.01.2017
Most recent event   Tooltip10.08.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
University of Maryland, Baltimore
620 West Lexington Street, 4th Floor
Baltimore, MD 21201-1627 / US
[2015/34]
Inventor(s)01 / GALEN, James E.
5807 Victor Drive
Eldersburg, Maryland 21784-8439 / US
02 / WANG, Jin-Yuan
13105 Shinnecock Drive
Silver Spring, Maryland 20904 / US
 [2015/34]
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [2015/34]Jones, Elizabeth Louise
Dehns
St Bride's House
10 Salisbury Square
London
EC4Y 8JD / GB
Application number, filing date13847433.314.10.2013
[2015/34]
WO2013US64872
Priority number, dateUS201261713806P15.10.2012         Original published format: US 201261713806 P
[2015/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014062580
Date:24.04.2014
Language:EN
[2014/17]
Type: A1 Application with search report 
No.:EP2906682
Date:19.08.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 24.04.2014 takes the place of the publication of the European patent application.
[2015/34]
Search report(s)International search report - published on:KR24.04.2014
(Supplementary) European search report - dispatched on:EP02.05.2016
ClassificationIPC:C12N1/21, C12N15/74, A61K39/112
[2015/34]
CPC:
C12N15/74 (EP,US); A61K39/0275 (US); A61K39/0291 (EP,US);
A61K39/08 (EP,US); A61K2039/522 (EP,US); A61K2039/523 (EP,US);
Y02A50/30 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/34]
TitleGerman:CHROMOSOMAL INTEGRIERTE FREMDANTIGENE EXPRIMIERENDE BAKTERIELLE LEBENDVEKTORIMPFSTOFFE[2015/34]
English:BACTERIAL LIVE VECTOR VACCINES EXPRESSING CHROMOSOMALLY-INTEGRATED FOREIGN ANTIGENS[2015/34]
French:VACCINS À VECTEUR BACTÉRIEN VIVANT EXPRIMANT DES ANTIGÈNES ÉTRANGERS INTÉGRÉS DANS UN CHROMOSOME[2015/34]
Entry into regional phase24.04.2015National basic fee paid 
24.04.2015Search fee paid 
24.04.2015Designation fee(s) paid 
24.04.2015Examination fee paid 
Examination procedure24.04.2015Examination requested  [2015/34]
23.03.2017Amendment by applicant (claims and/or description)
10.07.2018Despatch of a communication from the examining division (Time limit: M06)
21.01.2019Reply to a communication from the examining division
11.08.2021Despatch of a communication from the examining division (Time limit: M06)
16.03.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
25.05.2022Reply to a communication from the examining division
09.08.2024Despatch of a communication from the examining division (Time limit: M03)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.07.2018
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
25.05.2022Request for further processing filed
25.05.2022Full payment received (date of receipt of payment)
Request granted
08.06.2022Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
23.03.2017Request for further processing filed
23.03.2017Full payment received (date of receipt of payment)
Request granted
05.04.2017Decision despatched
Fees paidRenewal fee
27.10.2015Renewal fee patent year 03
27.10.2016Renewal fee patent year 04
27.10.2017Renewal fee patent year 05
29.10.2018Renewal fee patent year 06
28.10.2019Renewal fee patent year 07
27.10.2020Renewal fee patent year 08
27.10.2021Renewal fee patent year 09
27.10.2022Renewal fee patent year 10
27.10.2023Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XDY]WO0032047  (UNIV MARYLAND [US], et al);
 [XY]WO2011060431  (UNIV MARYLAND [US], et al);
International search[A]WO03097838  (COBRA THERAPEUTICS LTD [GB], et al);
 [A]US2008233094  (VINDURAMPULLE CHRISTOFER [AU], et al);
 [A]US2010112674  (GALEN JAMES E [US], et al);
 [X]  - GALEN, JAMES E. ET AL., "A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors", INFECT. IMMUN., (20091102), vol. 78, no. 1, pages 337 - 347, XP055043275

DOI:   http://dx.doi.org/10.1128/IAI.00916-09
 [A]  - GALEN, JAMES E. ET AL., "Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaicine", J. INFECT. DIS., (20090201), vol. 199, no. 3, pages 326 - 335, XP055243109

DOI:   http://dx.doi.org/10.1086/596066
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.